Pedro Garcia Gordo
Interventional Cardiology · Bayamon, PRNPI 1275789844
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 183 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for interventional cardiology clinicians in PR, where the typical reported total is $12,032.
Across 183 payments — averaging $18.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$753
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$539
- Medtronic$521
- Boston Scientific$449
- AstraZeneca$328
- Boehringer Ingelheim$231
- plus $590 from 11 others
Across 18 payments — averaging $3500.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$63K
What the payments were for
- Food & beverage$3,411100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 62 | $753 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 35 | $539 |
| Medtronic | 10 | $521 |
| Boston Scientific | 22 | $449 |
| AstraZeneca | 17 | $328 |
| Boehringer Ingelheim | 10 | $231 |
| E.r. Squibb & Sons, L.L.C. | 6 | $131 |
| Johnson & Johnson | 3 | $98 |
| Merck | 4 | $80 |
| Inari Medical, Inc. | 4 | $74 |
| PBG Puerto Rico LLC | 2 | $50 |
| Stryker | 2 | $41 |
| Amgen | 2 | $38 |
| Edwards Lifesciences | 1 | $25 |
| Scpharmaceuticals Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $16 |
| Cardinal Health P.r. 120 Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ONYX FRONTIER$163
- Micra$138
- SYNERGY$121
- Consulta$100
How this compares
$3,411 in reported general payments places this provider in the 25th percentile of 39 interventional cardiology providers in Puerto Rico.
See all interventional cardiology providers in Puerto Rico →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 168 | $166,067 |
| EliquisApixaban | 181 | $163,661 |
| XareltoRivaroxaban | 72 | $77,904 |
| BrilintaTicagrelor | 115 | $75,940 |
| FarxigaDapagliflozin Propanediol | 64 | $64,003 |
| OzempicSemaglutide | 32 | $31,290 |
| JardianceEmpagliflozin | 18 | $16,981 |
| Repatha SureclickEvolocumab | 20 | $11,509 |
| SynthroidLevothyroxine Sodium | 101 | $11,245 |
| Metoprolol Succinate | 389 | $7,361 |
| Repatha SyringeEvolocumab | 12 | $6,833 |
| Atorvastatin Calcium | 467 | $5,914 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $4,349 |
| ClopidogrelClopidogrel Bisulfate | 293 | $4,198 |
| Rosuvastatin Calcium | 218 | $3,930 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta, Farxiga | $328 | $139,943179 claims |
| Johnson & JohnsonXarelto | $98 | $77,90472 claims |
| Boehringer IngelheimJardiance | $231 | $16,98118 claims |
| MerckJanumet | $80 | $4,34912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 39 interventional cardiology providers in Puerto Rico.
Other interventional cardiology in Bayamon
- Ismael Ortiz-CartagenaBayamon$40K
- Oscar RiveraBayamon$3K
- James VilaroBayamon$505
- Damian Grovas AbadSan Juan$498K
- Eric Carro JimenezSan Juan$416K
- Hector Martinez GonzalezMayaguez$261K
- Alejandro Lopez MasPonce$142K
- Ricardo SantiagoManati$131K
- Edwin I Perez MarreroSan Juan$129K
- Pedro Colon HernandezCaguas$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.